[go: up one dir, main page]

BE1009520A5 - Acide (-)-(3r)-3-methyl-4- 4-[4-(4-pyridyl)-piperazin-1-yl] phenoxy butyrique. - Google Patents

Acide (-)-(3r)-3-methyl-4- 4-[4-(4-pyridyl)-piperazin-1-yl] phenoxy butyrique. Download PDF

Info

Publication number
BE1009520A5
BE1009520A5 BE9600491A BE9600491A BE1009520A5 BE 1009520 A5 BE1009520 A5 BE 1009520A5 BE 9600491 A BE9600491 A BE 9600491A BE 9600491 A BE9600491 A BE 9600491A BE 1009520 A5 BE1009520 A5 BE 1009520A5
Authority
BE
Belgium
Prior art keywords
pharmaceutically acceptable
optically active
ester
active compound
methyl
Prior art date
Application number
BE9600491A
Other languages
English (en)
French (fr)
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Application granted granted Critical
Publication of BE1009520A5 publication Critical patent/BE1009520A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE9600491A 1995-06-01 1996-05-31 Acide (-)-(3r)-3-methyl-4- 4-[4-(4-pyridyl)-piperazin-1-yl] phenoxy butyrique. BE1009520A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative

Publications (1)

Publication Number Publication Date
BE1009520A5 true BE1009520A5 (fr) 1997-04-01

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9600491A BE1009520A5 (fr) 1995-06-01 1996-05-31 Acide (-)-(3r)-3-methyl-4- 4-[4-(4-pyridyl)-piperazin-1-yl] phenoxy butyrique.

Country Status (31)

Country Link
EP (1) EP0796247A1 (sv)
JP (1) JP2885941B2 (sv)
KR (1) KR100245957B1 (sv)
AT (1) AT406675B (sv)
AU (1) AU710105B2 (sv)
BE (1) BE1009520A5 (sv)
BR (1) BR9606409A (sv)
CA (1) CA2194397A1 (sv)
CH (1) CH691808A5 (sv)
CZ (1) CZ26997A3 (sv)
DE (1) DE19680509T1 (sv)
DK (1) DK10697A (sv)
ES (1) ES2137886B1 (sv)
FI (1) FI970393L (sv)
GB (1) GB2304340B (sv)
GR (1) GR1002702B (sv)
HU (1) HUP9700274A3 (sv)
IE (1) IE960405A1 (sv)
IL (1) IL118477A0 (sv)
IT (1) IT1290839B1 (sv)
LU (1) LU90008B1 (sv)
MC (1) MC2418A1 (sv)
MX (1) MX9700379A (sv)
NL (1) NL1003243C2 (sv)
NO (1) NO307460B1 (sv)
NZ (1) NZ308597A (sv)
PL (1) PL318440A1 (sv)
SE (1) SE510812C2 (sv)
SK (1) SK13097A3 (sv)
TR (1) TR199700020T1 (sv)
WO (1) WO1996038416A1 (sv)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
WO1994022835A2 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors

Also Published As

Publication number Publication date
FI970393A0 (sv) 1997-01-30
BR9606409A (pt) 1997-09-30
AU5827296A (en) 1996-12-18
ES2137886B1 (es) 2000-08-16
SE510812C2 (sv) 1999-06-28
FI970393L (sv) 1997-01-30
IL118477A0 (en) 1996-09-12
GB9627127D0 (en) 1997-02-19
SE9700203D0 (sv) 1997-01-24
JPH09512836A (ja) 1997-12-22
NO307460B1 (no) 2000-04-10
CA2194397A1 (en) 1996-12-05
ITMI961113A1 (it) 1997-12-01
IE960405A1 (en) 1996-12-11
WO1996038416A1 (en) 1996-12-05
AT406675B (de) 2000-07-25
EP0796247A1 (en) 1997-09-24
DK10697A (da) 1997-04-01
HU9700274D0 (en) 1997-04-28
CZ26997A3 (en) 1997-08-13
MC2418A1 (fr) 1997-05-23
NZ308597A (en) 1998-11-25
AU710105B2 (en) 1999-09-16
MX9700379A (es) 1997-04-30
GB2304340A (en) 1997-03-19
GB2304340B (en) 1998-07-29
IT1290839B1 (it) 1998-12-14
NO970437L (no) 1997-02-20
JP2885941B2 (ja) 1999-04-26
ES2137886A1 (es) 1999-12-16
SK13097A3 (en) 1997-08-06
SE9700203L (sv) 1997-01-24
LU90008B1 (fr) 1997-04-16
DE19680509T1 (de) 1997-12-04
CH691808A5 (de) 2001-10-31
HUP9700274A3 (en) 2000-02-28
HUP9700274A2 (hu) 1999-06-28
KR100245957B1 (ko) 2000-04-01
ATA900596A (de) 1999-12-15
PL318440A1 (en) 1997-06-09
TR199700020T1 (tr) 1997-04-22
NO970437D0 (no) 1997-01-31
GR1002702B (el) 1997-05-22
NL1003243C2 (nl) 1996-12-04
KR970704689A (ko) 1997-09-06
ITMI961113A0 (it) 1996-05-31

Similar Documents

Publication Publication Date Title
FR2823209A1 (fr) Nouvelles thiohydantoines et leur utilisation en therapeutique
FR2694004A1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
EP0587499B1 (fr) Composés benzopyraniques, leur procédé de préparation et leur utilisation comme protecteurs cellulaires
EP1546111A2 (fr) Composes derives de la 2-thiohydantoine et leur utilisation pour le traitement du diabete
EP0841330B1 (fr) Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JPH072831A (ja) ベータ−３選択性アドレナリン作動剤としてのアミノシクロアルカノベンゾジオキソール類
FR2685329A1 (fr) Derives de 3(2h)-pyridazinone et procede pour les preparer.
CA2000091A1 (fr) Derives de la benzoxazolinone, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CA2089349C (fr) Nouveaux derives de pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2643634A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
EP2917204B1 (fr) Derives de 1h-indole-3-carboxamide et leurs utilisation comme antagonistes du p2y12
FR2559151A1 (fr) Derives de l'arginine et sels d'addition d'acides correspondants pharmaceutiquement acceptables et compositions pharmaceutiques les contenant
BE1009520A5 (fr) Acide (-)-(3r)-3-methyl-4- 4-[4-(4-pyridyl)-piperazin-1-yl] phenoxy butyrique.
FR2602231A1 (fr) Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2753970A1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
FR2641534A1 (fr) Nouveaux derives de glycine utiles comme medicaments antagonistes du thromboxane a2 et procede pour leur preparation
EP0718307A2 (fr) Dérivés de 1-oxo-2-(phénylsulfonyl-amino)pentylpipéridine, leur préparation et leur application en thérapeutique
FR2734818A1 (fr) Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant
EP1098888A1 (fr) Derives de piperazinones et leurs applications
CH641775A5 (fr) N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, son procede de preparation et composition le renferment.
EP0430800B1 (fr) Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
WO2000003986A1 (fr) Bispiperidines comme agents antithrombotiques
EP0395526A1 (fr) Nouveaux dérivés benzothiazolinoniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2539414A1 (fr) Derives de la pyrimidine, leur procede de preparation et les medicaments ayant une activite sur le systeme nerveux central qui en contiennent

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20040531